-
Mashup Score: 13
Given the advances in stent technology and the introduction of potent P2Y12-inhibitors, early de-escalation from dual antiplatelet therapy (DAPT) to P2Y12-inhib
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
AbstractAims. The relative safety and efficacy of de-escalation, extended duration (ED) (>12-months), and standard dual antiplatelet therapy for 12-months (D
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1P2Y12 inhibition in high bleeding risk patients: making the right decision in a complex setting - 8 month(s) ago
We read with great interest the SWEDEHEART report by Tjerkaski et al.1 regarding the comparison of ticagrelor vs. clopidogrel in patients with myocardial infarc
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Modulation and personalization of therapy after acute coronary syndromes: the road to precision - 10 month(s) ago
The mortality and morbidity associated with acute coronary syndromes (ACSs) have declined markedly over the past 50 years, mainly due to the introduction of the
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1New approaches to reduce recurrent PCI: to angioplasty and beyond! - 11 month(s) ago
Management of coronary artery disease (CAD) patients remains highly challenging, as underlined by the elevated residual risk of ischemic events,1 despite impres
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Modulation and personalization of therapy after acute coronary syndromes : the road to precision - 1 year(s) ago
Summary of our article published in Cardiopulse in the European Heart Journal (EHJ) with Giuseppe Biondi-Zoccai, Maciej Banach and Mattia Galli.
Source: YouTubeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 10Modulation and personalization of therapy after acute coronary syndromes: the road to precision - 1 year(s) ago
The mortality and morbidity associated with acute coronary syndromes (ACSs) have declined markedly over the past 50 years, mainly due to the introduction of the
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Modulation and personalization of therapy after acute coronary syndromes: the road to precision - 1 year(s) ago
The mortality and morbidity associated with acute coronary syndromes (ACSs) have declined markedly over the past 50 years, mainly due to the introduction of the
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Different aspects of giving the optimal antiplatelet treatment - 1 year(s) ago
Article Navigation Journal Article Stefan Agewall …
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation - 1 year(s) ago
AbstractAims. Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrillation
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
One-year follow-up of patients treated with #SAPT directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome https://t.co/L3IO2NqSHW